¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå : À¯Çüº°, ÀûÀÀÁõº°, Á¦Çüº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, Áö¿ªº°
Fast Melt Tablets Market, By Type, By Indication, By Dosage Form, By Age Group, By Distribution Channel, By Geography
»óǰÄÚµå : 1671839
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¼Ó¿ëÁ¤ ½ÃÀåÀº 2025³â 62¾ï ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 114¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 9.1%·Î È®´ëµÉ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 62¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£: 2025-2032³â CAGR: 9.10% 2032³â °¡Ä¡ ¿¹Ãø 114¾ï 1,000¸¸ ´Þ·¯
±×¸². ¼Ó¿ëÁ¤ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Fast Melt Tablets Market-IMG1

¼Ó¿ëÁ¤À̶õ, ¾Ã°Å³ª ¹°À» ÇÊ¿ä·Î ÇÏÁö ¾Ê°í ±¸°­³»¿¡¼­ ¼ø°£ÀûÀ¸·Î ºØ±«¡¤¿ëÇØÇÏ´Â ±¸°­³» ºØ±«Á¤À» °¡¸®Åµ´Ï´Ù. ±¸°­ ³»¿¡¼­ ½Å¼ÓÇÏ°Ô ºØ±«µÇ°Å³ª ¿ëÇØµÇµµ·Ï ÃÖÀûÀ¸·Î ¼³°èµÇ¾î »ïŰ±â°¡ ½¬¿öÁý´Ï´Ù. ¼Ó¿ëÁ¤Àº ÀϹÝÀûÀ¸·Î ¼Ò¾Æ, ³ëÀÎ, »ïŰ´Â Àå¾Ö°¡ Àִ ȯÀÚ µî ±âÁ¸ÀÇ Á¤Á¦³ª ĸ½¶À» »ïŰ±â°¡ ¾î·Á¿î ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ¼Ó¿ëÁ¤Àº Çù°­³»¿¡¼­ ¾àÁ¦°¡ ¿ëÇØ¡¤¹æÃâµÇµµ·Ï ¼³°èµÇ¾î Àֱ⠶§¹®¿¡ »ï۱⸦ À§ÇØ ¹°À» ÇÊ¿ä·Î ÇÏÁö ¾Ê½À´Ï´Ù. ÀÌ ±â¼úÀº »ïŰ´Â ±â´ÉÀÌ ÀúÇÏµÈ È¯ÀÚ¿¡°Ô Åõ¿©¸¦ ¿ëÀÌÇÏ°Ô Çϰí ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ Çâ»ó½Ãŵ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀåÀº ±âÁ¸ÀÇ Á¤Á¦³ª ĸ½¶ÀÇ »ïŰ±â°¡ ¾î·Á¿î ³ëÀÎ Àα¸ Áõ°¡°¡ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¾ïÁ¦¿äÀÎÀº ±âÁ¸ Á¤Á¦¿Í ºñ±³ÇÏ¿© ºü¸¥ ¿ëÁ¤ Á¦Á¶ ºñ¿ëÀÌ ³ô´Ù´Â °ÍÀÔ´Ï´Ù. ±×·¯³ª, ȯÀÚÀÇ ÄÄÇöóÀ̾𽺰¡ Çâ»óµÇ°í, ƯÈ÷ ¼Ò¾Æ ¹× ³ë³â ȯÀÚ¿¡°Ô Åõ¿©°¡ °£ÆíÇØÁö´Â µîÀÇ ÀÌÁ¡ÀÌ Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ Áß¿¡ ½ÃÀå ¼ºÀåÀÇ À¯¸®ÇÑ ±âȸ°¡ ÃÊ·¡µÉ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» ³ªÅ¸³À´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.

¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¾÷Àû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¼Ó¿ëÁ¤ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Mylan NV, Amgen Inc., Allergan plhar, Aurobindo Pharma ries Ltd., Strides Pharma Science Limited, and Zydus Cadila µîÀÌ Æ÷ÇԵ˴ϴÙ.

ÀÌ º¸°í¼­ÀÇ ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, À¯Çüº°, 2020-2032³â,(10¾ï ´Þ·¯)

Á¦5Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, ÀûÀÀÁõº°, 2020-2032³â,(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, Á¦Çüº°, 2020-2032³â,(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, ¿¬·ÉÃþº°, 2020-2032³â,(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â,(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ¼Ó¿ëÁ¤ ½ÃÀå, Áö¿ªº°, 2020-2032³â, °¡Ä¡(10¾ï ´Þ·¯)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ºÐ¼®°¡ Ãßõ

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Fast Melt Tablets Market is estimated to be valued at USD 6.20 Bn in 2025 and is expected to reach USD 11.41 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.20 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 11.41 Bn
Figure. Fast Melt Tablets Market Share (%), By Region, 2025
Fast Melt Tablets Market - IMG1

Fast melt tablets refer to orally disintegrating tablets that disintegrate or dissolve instantaneously in the oral cavity without chewing or the need of water. They are optimally designed to rapidly disintegrate or dissolve in the mouth, thereby facilitating swallowing. Fast melt tablets generally target patients who experience difficulties in swallowing conventional tablets and capsules such as pediatric, geriatric patients, and those with dysphagia. Rapidly dissolving tablets are designed to dissolve and release the drugs in buccal cavity eliminating the need of water for swallowing. This technology offers ease of administration to patients with impaired ability to swallow and enhances patient compliance.

Market Dynamics:

The global fast melt tablets market is driven by growing geriatric population who experience difficulty in swallowing conventional tablets and capsules. The key restraining factor includes high cost of manufacturing fast melt tablets as compared to conventional tablets. However, advantages such as enhanced patient compliance and convenience of administration especially for pediatric and geriatric patients is expected to provide lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fast melt tablets market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fast melt tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadila

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fast melt tablets market

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Fast Melt Tablets Market, By Type, 2020-2032, (USD Bn)

5. Global Fast Melt Tablets Market, By Indication, 2020-2032, (USD Bn)

6. Global Fast Melt Tablets Market, By Dosage Form, 2020-2032, (USD Bn)

7. Global Fast Melt Tablets Market, By Age Group, 2020-2032, (USD Bn)

8. Global Fast Melt Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

9. Global Fast Melt Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â